Bicarbonate

Bicarbonate

SCHEMBL47980

CC.CC.O=C(O)O.O=C(O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.71
CA2 P00918 1/20 0.71
CA9 Q16790 1/20 0.71
FFAR3 O14843 3/20 0.56
LCK P06239 1/20 0.56
FYN P06241 1/20 0.56
LMNA P02545 3/20 0.44
TSHR P16473 3/20 0.40
ACHE P22303 1/20 0.40
THPO P40225 1/20 0.40
TP53 P04637 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
LDHA P00338 2/20 0.33
LDHB P07195 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL11280337 1.00
Bicarbonate SCHEMBL29181726 1.00 CA1 (0.71) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL28577539 1.00 CA1 (0.71) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL27082179 1.00 CA1 (0.71) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL28358443 0.94 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL12489460 0.94 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL641446 0.94 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL2890152 0.94 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL5082549 0.94 CA1 (0.62) CA1CA2CA9FFAR3LCK
Bicarbonate SCHEMBL27691058 0.94 CA1 (0.62) CA1CA2CA9FFAR3LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688908-A2 CROSSLINKED POLYESTER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF Momentive Performance Materials Inc. (US) 2026-02-11 EP claimed
EP-3768816-B1 METHOD AND DEVICE FOR THE PRESERVATION OF LIQUIDS CONTAINING WINE LANXESS DEUTSCHLAND GMBH (DE) 2025-10-08 EP claimed
US-20250215003-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF RUXOLITINIB GRANULES INDIA LIMITED (IN) 2025-07-03 US claimed
US-12288877-B2 Rechargeable metal halide battery with intercalation anode INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2025-04-29 US claimed
WO-2025071268-A1 POLYESTER RESIN HAVING EXCELLENT MECHANICAL PROPERTIES AND BIODEGRADABILITY, AND PREPARATION METHOD THEREFOR 주식회사 삼양사 2025-04-03 WO claimed
EP-3713848-B1 DICARBONIC ACID CONTAINING ALUMINIUM CONTAINER LANXESS DEUTSCHLAND GMBH (DE) 2025-03-12 EP claimed
US-12234234-B2 Method for synthesizing 1,7-naphthyridine derivatives CHENGDA PHARMACEUTICALS CO., LTD. (CN) 2025-02-25 US claimed
CN-116375706-B Abamectin sodium key intermediate and preparation method thereof 时森海(杭州)医药科技有限公司 2025-02-14 CN claimed
CN-119032095-A Improved process for preparing ruxolitinib 印度颗粒有限公司 2024-11-26 CN claimed
EP-4463460-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF RUXOLITINIB Granules India Limited (IN) 2024-11-20 EP claimed
EP-1174940-A1 Non-aqueous electrochemical apparatus MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2002-01-23 EP claimed
US-20010038949-A1 Stability; electrolyte mixture containing surfactant MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2001-11-08 US claimed
EP-1146586-A2 Non-aqueous electrolyte secondary battery MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2001-10-17 EP claimed
US-20010008658-A1 ADDITIVE TRANSFER FILM SUITABLE FOR COOK-IN END USE CRYOVAC, INC. 2001-07-19 US claimed
US-6153696-A Process for forming carbonates of hydroxyaromatic compounds INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2000-11-28 US claimed
US-6020386-A REACTING A POLY(UREA)URETHANE WITH WASTES WITH POLYOL; HEATING; THEN DIALKYL CARBONATE BAYER AKTIENGESELLSCHAFT (DE) 2000-02-01 US claimed
EP-0954545-A1 ADDITIVE TRANSFER FILM SUITABLE FOR COOK-IN END USE Cryovac, Inc. (US) 1999-11-10 EP claimed
EP-0610719-B1 Process for the preparation of hydroxyl group containing compounds from (polyurethane) polyurea waste BAYER AG (DE) 1999-04-07 EP claimed
WO-1998031731-A1 ADDITIVE TRANSFER FILM SUITABLE FOR COOK-IN END USE CRYOVAC, INC. (US) 1998-07-23 WO claimed
US-4087543-A Composition for disinfecting soil and combating plant diseases containing organic dicarbonates BAYER AKTIENGESELLSCHAFT (DT) 1978-05-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12234234-B2 Method for synthesizing 1,7-naphthyridine derivatives ALDH7A1, AKR7A2, APEH CA1 1106/4885CA2 1013/4885CA9 231/4885
US-20250215003-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF RUXOLITINIB JAK1, JAK3, JAK2 CA1 4690/4885CA2 4017/4885CA9 3524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.